Column Capital Advisors’s Audentes Therapeutics, Inc BOLD Stock Holding History

Column Capital Advisors’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-55	Closed	-$3K	–	829
2019 Q4	$3K	Buy	+55	New	+$2.06K	﹤0.01%	598

Column Capital Advisors's BOLD Position: Q1 2020 in Review

Column Capital Advisors sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 55 shares — an estimated $3K sold.

Column Capital Advisors first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $3K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Column Capital Advisors reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Column Capital Advisors sold 55 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $3K.
Column Capital Advisors first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
Column Capital Advisors's Audentes Therapeutics, Inc position peaked at $3K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Column Capital Advisors's 13F filing for Q1 2020, filed 11 May 2020.